Skip to main content
Caplight Logo









iLoF

iLoF

Private
LondonHealthcare & Life Scienceshttps://ilof.tech/

Last Round

SAFE

Mar 9, 2026

Total Funding Raised

$12.67M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

iLoF is a digital health company with an AI and photonics platform that creates a digital library of biomarkers to accelerate personalized drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Clinical Trials, Medical AI, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

biomarker discoverypatient stratificationclinical trial optimizationAI drug discoverydigital biomarkerspatient screeningprecision medicinephotonicsnon-invasive screeningoptical fingerprintsdrug development toolsmedical AIbiomarker libraryAlzheimer's diseaseneurodegenerative diseases

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iLoF Comparables

Compare iLoF with similar companies based on industry and business-model similarity.

iLoF comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sonrai Analytics
81%
Aignostics
73%
Insitro
65%

iLoF Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SAFEMar 9, 2026
StrategicOct 22, 2024
GrantJul 31, 2024
AcceleratorJan 1, 2023
SeedJul 28, 2022
Grant
Jul 28, 2022

Key People

Founding team and executive leadership

Mehak Mumtaz

COO & Co-Founder

Founding Team

Bernardo Alba

Founders Senior Associate CEO Office

Founding Team

Luis Valente

CEO & Co-Founder

Founding Team

iLoF Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    Monthly visitors grew 122% MoM, reaching 3K.

  • Mar 9, 2026

    $231K raised from Hamamatsu Ventures, M12, and others.

iLoF Filings

Explore SEC and related filing metadata, where available.

iLoF filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about iLoF's valuation, stock price, and market status.

Is iLoF a public or private company?

iLoF is a private company.

What is the current stock price of iLoF?

iLoF is a private company with no public stock price. No recent secondary market data is available.

How much is iLoF worth (valuation)?

Valuation information for iLoF is not publicly available.

Can I buy iLoF stock?

iLoF shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was iLoF's last funding round?

iLoF's most recent funding round was SAFE on March 9, 2026.

Who are the main investors in iLoF?

Key investors in iLoF include Faber Ventures.

Will iLoF IPO soon?

No public IPO plans have been announced for iLoF.

How can I track iLoF secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor iLoF's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range40
Year Founded2019
Last FundingMar 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?